These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. [Effect of the administration of silymarin on serum lipid levels]. Petronelli A, Roda E, Briganti M, Morselli Labate AM, Barbara L. Clin Ter; 1981 Dec 15; 99(5):471-82. PubMed ID: 7333068 [No Abstract] [Full Text] [Related]
32. [Toxic occupational liver diseases. Therapeutic effects of silymarin]. Boari C, Montanari FM, Galletti GP, Rizzoli D, Baldi E, Caudarella R, Gennari P. Minerva Med; 1981 Oct 20; 72(40):2679-88. PubMed ID: 7290471 [Abstract] [Full Text] [Related]
33. Resolution of liver fibrosis in chronic CCl4 administration in the rat after discontinuation of treatment: effect of silymarin, silibinin, colchicine and trimethylcolchicinic acid. Muriel P, Moreno MG, Hernández Mdel C, Chávez E, Alcantar LK. Basic Clin Pharmacol Toxicol; 2005 May 20; 96(5):375-80. PubMed ID: 15853930 [Abstract] [Full Text] [Related]
34. [Legalon in the complex treatment of patients with hepatic stasis in chronic circulatory insufficiency]. Krylov AA. Vrach Delo; 1984 Mar 20; (3):22-3. PubMed ID: 6719894 [No Abstract] [Full Text] [Related]
35. [Milk thistle (Silybum marianum) derivatives in the therapy of chronic hepatopathies]. De Martiis M, Fontana M, Assogna G, D'Ottavi R, D'Ottavi O. Clin Ter; 1980 Aug 15; 94(3):283-315. PubMed ID: 7004762 [No Abstract] [Full Text] [Related]
38. [Results of tests of the hepatoprotective effect of silymarin in experimental animals]. Siblíková O, Trcka V, Vakocová H, Tichý M. Cas Lek Cesk; 1985 Feb 08; 124(6):165-9. PubMed ID: 3971403 [No Abstract] [Full Text] [Related]
39. Proceedings: Silybin - a prophylactic or curative phalloidin antidote? Braatz R. Naunyn Schmiedebergs Arch Pharmacol; 1975 Feb 08; 287 Suppl():R104. PubMed ID: 1143373 [No Abstract] [Full Text] [Related]